
PI3K-Akt is an important signal transduction pathway which acts downstream from various growth factor receptors. The PI3K-Akt pathway is activated in many types of cancers by several mechanisms, including growth factor receptor activation, loss of PTEN, and PI3K gene mutations. Therefore, PI3K is thought to be an ideal therapeutic target. A large number of PI3K inhibitors are being developed and evaluated in clinical trials.
Phosphatidylinositol 3-Kinases, Neoplasms, Humans, Molecular Targeted Therapy, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Phosphoinositide-3 Kinase Inhibitors, Signal Transduction
Phosphatidylinositol 3-Kinases, Neoplasms, Humans, Molecular Targeted Therapy, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Phosphoinositide-3 Kinase Inhibitors, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
